Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/02/1994 | EP0622081A2 Epitopic regions of phneumococcal surface protein A |
11/02/1994 | EP0621898A1 Chimeric immunogens |
11/02/1994 | EP0621893A1 Feline leukemia virus vaccines |
11/02/1994 | EP0621865A1 Rapamycin derivative and its medicinal use |
11/02/1994 | EP0621790A1 Attenuated, live vaccine for delaware strain ibdv |
11/02/1994 | EP0621788A1 Hemoregulatory peptides |
11/02/1994 | EP0621783A1 Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative |
11/02/1994 | EP0621778A1 $i(M. FERMENTANS) INFECTION TREATMENT |
11/02/1994 | EP0411111B1 Ammonium compound, composition containing it and desinfection method |
11/02/1994 | CN1094399A Inhibitors of HIV protease useful for the treatment of aids |
11/02/1994 | CN1094310A Combination chemotherapy for HIV infections |
11/02/1994 | CN1094218A Combating fish parasites |
11/01/1994 | US5360817 Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents |
11/01/1994 | US5360798 Bactericides |
11/01/1994 | US5360734 Viricides for blood with photoactive materials, radiation a mixture with proteins |
10/30/1994 | CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors |
10/28/1994 | WO1993022370A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy |
10/28/1994 | CA2134346A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy |
10/27/1994 | WO1994024298A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
10/27/1994 | WO1994024296A2 Recombinant bovine herpesvirus type 1 vaccines |
10/27/1994 | WO1994024268A1 Recombinant avian adenovirus vector |
10/27/1994 | WO1994024168A1 Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof |
10/27/1994 | WO1994024167A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
10/27/1994 | WO1994024143A1 Method of forming oligonucleotides |
10/27/1994 | WO1994024134A1 New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use |
10/27/1994 | WO1994024130A1 New pyridinium salts and their use for controlling helicobacter bacteria |
10/27/1994 | WO1994023746A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
10/27/1994 | WO1994023742A1 Methods and compositions for the prevention or treatment of sexually transmitted diseases |
10/27/1994 | WO1994023718A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease |
10/27/1994 | WO1994023709A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
10/27/1994 | CA2161122A1 Biocompatible implant for expression and secretion of a therapeutic compound in vivo |
10/27/1994 | CA2160983A1 Immunonanoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof |
10/27/1994 | CA2137833A1 Amino-sugars and glycoproteins, and methods for their preparation; pharmaceutical preparations containing these amino-sugars or glycoproteins, and the uses of these pharmaceuticalpreparations |
10/27/1994 | CA2137148A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease |
10/26/1994 | EP0621031A2 Ointment for wound treatment |
10/26/1994 | EP0620860A1 Preparation of recombinant borrelia proteins |
10/26/1994 | EP0620850A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
10/26/1994 | EP0620833A1 Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process |
10/26/1994 | EP0620821A1 Antiviral compositions and method for their use |
10/26/1994 | EP0620811A1 Heterocycle-substituted benzylamine derivatives as antiretroviral compounds |
10/26/1994 | EP0620734A1 Therapeutic nucleosides |
10/26/1994 | EP0486536B1 Antiviral compositions containing sulfoquinovosyl glycerol derivatives and analogs thereof |
10/26/1994 | CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
10/26/1994 | CN1094046A Novel compounds |
10/26/1994 | CN1094034A 25Carboxylic derivative of vitamin D series, middle products in production of same and pharmaceutical containing same and use of same in treatment |
10/26/1994 | CN1094028A Catechol diethers as selective PDE(IV) inhibitors |
10/26/1994 | CN1093904A Compositions for the regulation of cytokine activity |
10/25/1994 | US5359088 Enantiomerically pure aminopyrrolidine compounds |
10/25/1994 | US5359051 Compounds useful in the synthesis of nucleic acids capable of cleaning RNA |
10/25/1994 | US5358866 Using cytosine deaminase as marker |
10/21/1994 | CA2121613A1 Active compound from a sponge |
10/21/1994 | CA2116261A1 Epitopic regions of pneumococcal surface protein a |
10/19/1994 | EP0620277A1 Nucleic acid pharmaceuticals |
10/19/1994 | EP0620232A1 Aza cyclohexapeptide compounds |
10/19/1994 | EP0620225A1 Cephalosporin derivatives |
10/19/1994 | EP0620215A1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors |
10/19/1994 | EP0620214A1 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors |
10/19/1994 | EP0620010A1 HIV related peptides |
10/19/1994 | EP0620009A1 HIV related peptides |
10/19/1994 | EP0619840A1 Pseudorabies virus vaccine |
10/19/1994 | EP0619813A1 Linked cyclic polyamines with activity against hiv |
10/19/1994 | EP0619742A1 Transfection of lung via aerosolized transgene delivery |
10/19/1994 | EP0619741A1 Polar lipid composition of plant origin |
10/19/1994 | EP0619736A1 Antiparasitic oligonucleotides active against drug resistant malaria |
10/19/1994 | EP0577760A4 Sequential dosing of antifungal and antiinflammatory compositions. |
10/19/1994 | EP0546018B1 Pharmaceutical composition of florfenicol |
10/19/1994 | EP0471701B1 Novel tnf-inhibit proteins and their preparation |
10/19/1994 | EP0428605B1 Synthetic receptor analogues |
10/19/1994 | EP0413006B1 Hydroxyalkane carboxylic acid derivates and their use |
10/19/1994 | CN1093701A Antiretroviral hydrazine derivatives |
10/19/1994 | CN1093578A Prophylactic and curing agent for viral diseases of fish and crustaceans, and feed |
10/18/1994 | US5356889 Carbapenicillins |
10/18/1994 | US5356886 Treating herpes virus infections |
10/18/1994 | US5356882 Antiviral pyrimidine nucleosides |
10/18/1994 | CA1332556C Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2-phenoxyethyl)-ammonium bromide and methods of using the same |
10/17/1994 | CA2121323A1 1h-indole-3-acetamide spla2 inhibitors |
10/17/1994 | CA2121321A1 1h-indole-3-acetic acid hydrazide spla2 inhibitors |
10/13/1994 | WO1994023059A2 Anti-microbial agents and screening method therefor |
10/13/1994 | WO1994023050A1 Targeted delivery of genes encoding antisense polyribonucleotides |
10/13/1994 | WO1994023041A2 Method for selective inactivation of viral replication |
10/13/1994 | WO1994023037A1 Pharmaceuticals based on papillomaviruses |
10/13/1994 | WO1994023028A2 Modified oligonucleotides having improved anti-influenza activity |
10/13/1994 | WO1994023019A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof |
10/13/1994 | WO1994022892A1 7-deazapurine modified oligonucleotides |
10/13/1994 | WO1994022891A1 Oligonucleotides with amide linkages replacing phosphodiester linkages |
10/13/1994 | WO1994022888A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
10/13/1994 | WO1994022887A1 New antiviral compounds |
10/13/1994 | WO1994022882A1 Unsaturated phosphonates derivatives of purines and pyrimidines |
10/13/1994 | WO1994022876A1 Pyrrolo(1,2-b)-(1,2)-benzothiazin-10-one and its use as an antimicrobial |
10/13/1994 | WO1994022873A1 Diamine salts of clavulanic acid |
10/13/1994 | WO1994022863A1 Second messenger cell signaling inhibitors |
10/13/1994 | WO1994022488A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION |
10/13/1994 | WO1994022480A1 Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids |
10/13/1994 | WO1994022479A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
10/13/1994 | WO1994022477A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
10/13/1994 | WO1994022476A1 Multicomponent clostridial vaccines using saponin adjuvants |
10/13/1994 | WO1994022462A1 Anti-aids immunomodulator complex |
10/13/1994 | WO1994022459A1 Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic |
10/13/1994 | WO1994022448A1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
10/13/1994 | CA2164123A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |